Skip to content
Screener

Enterprise value at other companies

Thermo Fisher Scientific logo
Thermo Fisher ScientificTMO
$225.77B+21.7%
Danaher logo
DanaherDHR
$158.33B+0.9%
Repligen logo
RepligenRGEN
$7.78B+22.1%
Bio-Rad Laboratories logo
Bio-Rad LaboratoriesBIO
$8B+4.2%
Ginkgo Bioworks logo
Ginkgo BioworksDNA
$879.46M+22.9%
Charles River Laboratories logo
Charles River LaboratoriesCRL
$13.73B+38.4%

Other financials

Income statement

See full
Revenue$51.4M+8.5%
Gross profit$20.7M+166%
Operating income-$15.1M+77.2%
Net income-$12.4M+68.6%
EPS (diluted)-$0.08+70.4%

Balance sheet

See full
Cash & equivalents$70.6M-73.8%
Total debt$176.7M-52.4%
Total equity$204.6M-23.0%
Total assets$603.7M-32.7%

Cash flow

See full
Operating cash flow$4.0M+139%
CapEx$370.0K-87.1%
Free cash flow$3.6M+128%

Valuation

See full
Market cap$918.96M+210%
P/S4.4×+3.1×

Profitability

See full
Gross margin34.9%+4.4pp
Operating margin-56.1%-21.3pp
Net margin-37.1%-13.6pp
FCF margin-17.2%

Returns & leverage

See full
Return on equity-32.9%-9.4pp
Debt / equity0.9×-0.5×
Current ratio4.1×-1.1×

Where this comes from

Calculated from Maravai LifeSciences Holdings, Inc.’s reported figures.

The source filing: Maravai LifeSciences Holdings, Inc.’s 10-Q, filed August 7, 2026. Open the filing →

Filed
Aug 7, 2026, 4:03 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001823239-26-000059

FAQ

What is Maravai LifeSciences Holdings, Inc.'s enterprise value?
Maravai LifeSciences Holdings, Inc. (MRVI) reported enterprise value of $1.03B in Q2 2026.
How has Maravai LifeSciences Holdings, Inc.'s enterprise value changed year-over-year?
Maravai LifeSciences Holdings, Inc.'s enterprise value increased by 143.1% year-over-year, from $422.24M to $1.03B.
What is the long-term trend for Maravai LifeSciences Holdings, Inc.'s enterprise value?
Over 5 years (2020 to 2025), Maravai LifeSciences Holdings, Inc.'s enterprise value has grown at a -35.4% compound annual growth rate (CAGR), from $5.52B to $619.14M.
What does enterprise value mean?
Market capitalization plus total debt minus cash, at the quarter end. The cost to acquire the whole business — what an buyer pays for equity and debt, net of the cash they'd inherit.

Ask your AI about Maravai LifeSciences Holdings, Inc.'s enterprise value.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude